{"paper_id": "0092846a890dd9dfd5e55d0731eee0175e485c08", "metadata": {"title": "Supplementary appendix", "authors": []}, "abstract": [], "body_text": [{"text": "-Secondary efficacy parameters, by days of illness and treatment arm (ITT analysis in the Primary Efficacy Population). ", "cite_spans": [], "ref_spans": [], "section": ""}, {"text": "Not hospitalized with resumption of normal activities 25 (29%) 15 (60%) 5 (18%) 2 (12%) 3 (18%) Not hospitalized, but unable to resume normal activities 6 (7%) 3 (12%) 1 (4%) 2 (12%) 0 (0%) Non-ICU hospitalization, not requiring supplemental oxygen 5 (6%) 0 (0%) 3 (11%) 0 (0%) 2 (12%) Non-ICU hospitalization, requiring supplemental oxygen", "cite_spans": [], "ref_spans": [], "section": "Supplimentary"}, {"text": "Median (Q1, Q3) 9 (4, 21) 4 (3, 8) 11.0 (4.5, 24.0) 15 (8, 26) 11 (5, 25) ", "cite_spans": [], "ref_spans": [], "section": "Supplimentary"}, {"text": "RT-PCR RNA isolated from nasal and oral swabs, and endotracheal aspirate samples when available, were used to type the samples into influenza A, and B positive and further subtype the influenza A positive samples to H1 and H3 as previously described. [1, 2] The amount of influenza A and B viral RNA copies was determined by quantitative real-time PCR using in vitro generated influenza A and B viral RNA as reference standard.", "cite_spans": [{"start": 251, "end": 254, "text": "[1,", "ref_id": "BIBREF0"}, {"start": 255, "end": 257, "text": "2]", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "Supplemental methods:"}, {"text": "Hemagglutination Inhibition (HAI) Assay Sera samples were treated with RDE (Denka Seiken) and hem-adsorbed before use in the HAI testing. Serial 2-fold dilution of the RDE and hem-adsorbed treated samples were prepared in Vbottom 96 well plates to which a fixed amount of influenza virus (4 HA units) was added and mixed. An equal volume of 0.5% turkey RBCs (Lampire Biological) suspension was added and plates were incubated for about one hour until HA activity was observed in virus control. The plates were tilted to read and the HAI titer was reported as the last dilution of sera with no hemagglutination activity. [3] ", "cite_spans": [{"start": 620, "end": 623, "text": "[3]", "ref_id": "BIBREF2"}], "ref_spans": [], "section": "Supplemental methods:"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus", "authors": [{"first": "B", "middle": [], "last": "Shu", "suffix": ""}], "year": 2011, "venue": "J Clin Microbiol", "volume": "49", "issn": "7", "pages": "2614--2623", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "510(k) Summary for Centers for Disease Control and Prevention human influenza virus real-time RT-PCR detection and characterization panel", "authors": [], "year": 2008, "venue": "CDC", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Manual for the laboratory diagnosis and virological surveillance of influenza", "authors": [], "year": 2011, "venue": "World Health Organization", "volume": "139", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Lin (PI), Janice Fritsche, RN, Tondria Green, RN, Bruce McLeod, MD, Deena Patel Naval Medical Center San Diego Mary F. Bavaro (PI), Robert Deiss, Carolyn Brandt, Stephanie Cammarata, Allan Kremp, Karine Hollis-Perry Naval Medical Center Portsmouth Tahaniyat Lalani, (PI), Susan Banks, Jacqueline Johnson, Jason Maguire, Janet McNiff, Leslie E Rigg. Walter Reed National Military Medical Center Anuradha Ganesan (PI), Irma Barahona, Janine Danko, Steven Spencer, David Stagliano, Timothy Burgess Beth Israel Deaconess Medical Center Daniel Talmor (PI), Monique Mohammed, Valerie Banner-Goodspeed Case Western Reserve University School of Medicine Robert Salata (PI) University of Massachusetts Medical Robert Finberg (PI), Jennifer Wang, Karen Longtine, Jaclyn Longtine, and Mellissa O'Neil Mayo Clinic Philippe R. Bauer (PI), Ognjen Gajic, Suanne M. Weist Emory University Jonathan Sevransky (PI), Mona Brown, John Roback Mount Sinai Medical Center John Oropello (PI), Bridget Twohig, Jeffrey Jhang, Brigham and Women's Hospital Rahgu Seethala (PI) Supplemental", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Proportion of participants with normalized respiratory status over time, by randomized treatment and oxygen at randomization (ITT analysis in the Primary Efficacy Population). Proportion of participants with normalized respiratory status over time, by randomized treatment and mechanical ventilator at randomization (ITT analysis in the Primary Efficacy Population). Proportion of participants with normalized respiratory status over time, by randomized treatment and ICU at randomization (ITT analysis in the Primary Efficacy Population). Proportion of participants with normalized respiratory status over time, by randomized treatment and ARDS at randomization (ITT analysis in the Primary Efficacy Population). Proportion of participants without symptoms present over time, by randomized treatment (ITT analysis in the Primary Efficacy Population). Shaded areas denote 95% confidence intervals, P+S = subjects randomized to receive plasma plus standard care, S = standard care alone. Proportion of participants without fever present over time, by randomized treatment (ITT analysis in the Primary Efficacy Population).", "latex": null, "type": "figure"}, "TABREF0": {"text": "Disposition and other secondary endpoints by randomized treatment and days from onset of symptoms to randomization (PEP; ITT analysis)", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>Total </td><td>\u00a0</td><td>\u00a0</td><td>Anti-influenza Plasma + </td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Anti-influenza Plasma + Standard Care </td><td>Standard Care Alone\n</td><td>Standard Care </td><td>Standard Care Alone\n</td></tr><tr><td>Disposition after last hospital discharge\nReleased home - home health care not required </td><td>(N=87) </td><td>\u2264 4 days (N=25) </td><td>\u2264 4 days (N=28) </td><td>&gt; 4 days (N=17) </td><td>&gt; 4 days (N=17)\n</td></tr><tr><td>35 (41%) </td><td>16 (64%) </td><td>11 (42%) </td><td>5 (29%) </td><td>3 (18%) </td></tr><tr><td>Released home with home health care </td><td>13 (15%) </td><td>4 (16%) </td><td>4 (15%) </td><td>3 (18%) </td><td>2 (12%) </td></tr><tr><td>Transferred to long term care facility </td><td>12 (14%) </td><td>2 (8%) </td><td>5 (19%) </td><td>4 (24%) </td><td>1 (6%) </td></tr><tr><td>Hospitalization ongoing at Day 28 </td><td>18 (21%) </td><td>2 (8%) </td><td>4 (15%) </td><td>5 (29%) </td><td>7 (41%) </td></tr><tr><td>Discharged to hospice care - home or inpatient </td><td>1 (1%) </td><td>0 (0%) </td><td>1 (4%) </td><td>0 (0%) </td><td>0 (0%) </td></tr><tr><td>Deceased </td><td>6 (7%) </td><td>1 (4%) </td><td>1 (4%) </td><td>0 (0%) </td><td>4 (24%) </td></tr><tr><td>Ordinal Scale Clinical Status at Day 7\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Not hospitalized with resumption of normal activities </td><td>25 (29%) </td><td>15 (60%) </td><td>5 (18%) </td><td>2 (12%) </td><td>3 (18%) </td></tr><tr><td>Not hospitalized, but unable to resume normal activities </td><td>6 (7%) </td><td>3 (12%) </td><td>1 (4%) </td><td>2 (12%) </td><td>0 (0%) </td></tr><tr><td>Non-ICU hospitalization, not requiring supplemental oxygen </td><td>5 (6%) </td><td>0 (0%) </td><td>3 (11%) </td><td>0 (0%) </td><td>2 (12%) </td></tr><tr><td>Non-ICU hospitalization, requiring supplemental oxygen </td><td>19 (22%) </td><td>3 (12%) </td><td>8 (29%) </td><td>4 (24%) </td><td>4 (24%) </td></tr><tr><td>In the intensive care unit (ICU) </td><td>27 (31%) </td><td>4 (16%) </td><td>10 (36%) </td><td>9 (53%) </td><td>4 (24%) </td></tr><tr><td>Death </td><td>5 (6%) </td><td>0 (0%) </td><td>1 (4%) </td><td>0 (0%) </td><td>4 (24%) </td></tr><tr><td>Days in hospital\nMedian (Q1, Q3) </td><td>9 (4, 21) </td><td>4 (3, 8) </td><td>11.0 (4.5, 24.0) </td><td>15 (8, 26) </td><td>11 (5, 25) </td></tr><tr><td>Number of hospital admissions\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>1 </td><td>78 (90%) </td><td>25 (100%) </td><td>25 (89%) </td><td>15 (88%) </td><td>13 (76%) </td></tr><tr><td>2 </td><td>7 (8%) </td><td>0 (0%) </td><td>2 (7%) </td><td>2 (12%) </td><td>3 (18%) </td></tr><tr><td>4 </td><td>2 (2%) </td><td>0 (0%) </td><td>1 (4%) </td><td>0 (0%) </td><td>1 (6%) </td></tr><tr><td>ICU admission\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>No </td><td>32 (37%) </td><td>14 (56%) </td><td>9 (32%) </td><td>4 (24%) </td><td>5 (29%) </td></tr><tr><td>Yes - 1 or more episodes </td><td>50 (57%) </td><td>11 (44%) </td><td>19 (68%) </td><td>13 (76%) </td><td>12 (71%)\n</td></tr><tr><td>Days in ICU\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Median (Q1, Q3) </td><td>3 (0, 12) </td><td>0 (0, 5) </td><td>4.0 (0.0, 12.5) </td><td>8 (2, 23) </td><td>2 (0, 16) </td></tr><tr><td>Supplemental oxygen\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>No </td><td>12 (14%) </td><td>6 (24%) </td><td>3 (11%) </td><td>2 (12%) </td><td>1 (6%) </td></tr><tr><td>Yes - 1 or more episodes </td><td>75 (86%) </td><td>19 (76%) </td><td>25 (89%) </td><td>15 (88%) </td><td>16 (94%)\n</td></tr><tr><td>Days on supplemental oxygen\n</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>Median (Q1, Q3) </td><td>8 (2, 28) </td><td>3 (1, 27) </td><td>11.0 (3.0, 28.5) </td><td>18 (6, 28) </td><td>5 (3, 22) </td></tr><tr><td>Mechanical ventilation\nNo </td><td>43 (49%) </td><td>17 (68%) </td><td>13 (46%) </td><td>7 (41%) </td><td>6 (35%) </td></tr><tr><td>Yes - 1 or more episodes </td><td>44 (51%) </td><td>8 (32%) </td><td>15 (54%) </td><td>10 (59%) </td><td>11 (65%)\n</td></tr><tr><td>Days on mechanical ventilation\nMedian (Q1, Q3) </td><td>1 (0, 11) </td><td>0 (0, 3) </td><td>2.5 (0.0, 11.0) </td><td>4 (0, 16) </td><td>3 (0, 15) </td></tr></table></body></html>"}}, "back_matter": []}